Australian Biotechnology News

Stories about: SAP

  • +

    Cracking down on counterfeit drugs 14/02/2005 14:45:07

    The makers of popular prescription drugs have found a new weapon in the fight against thieves and counterfeiters: the tiny and controversial radio frequency identification (RFID) chip.
  • +

    Simulated shades of Jurassic Park 02/12/2004 15:12:12

    Bioinformatics researchers at the University of California, Santa Cruz, have conducted an audacious project to recreate the genome sequence of an ancestral mammal that lived 70 to 80 million years ago.
  • +

    Peplin launches $10m fundraising bid 08/11/2004 14:00:15

    Brisbane cancer-drug developer Peplin (ASX:PEP) has announced a renounceable rights offer to shareholders aimed at raising AUD$10.2 million for the first Phase II clinical trial of its lead skin-cancer molecule, PEP005.
  • +

    Solbec plans psoriasis treatment trial 29/01/2004 15:16:22

    Perth drug discovery company Solbec Pharmaceuticals (ASX:SBP) has set out plans to trial its promising anti-cancer compound SBP002 as a treatment for the chronic skin disorder psoriasis this year.
  • +

    Peplin blames R&D expenditure for loss 09/09/2003 15:26:32

    Brisbane cancer-drug developer Peplin Biotech (ASX:PEP) has reported a consolidated loss of AUD$3.7 million for the 12 months to June 30, largely attributable to a big increase in research expenditure on its lead compound, PEP005.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Jobs